Chemotherapy less likely to benefit older patients with breast cancer
the ONA take:
Examining data from Surveillance, Epidemiology and End Results (SEER) database, researchers from The University of Texas Health Science Center at Houston (UTHealth) found that chemotherapy does not improve survival for older women with breast cancer.
SEER database provided information on 14,440 women with stage I to IIIA hormone receptor-negative breast cancer and 26,893 men and women with stage III colon cancer. All diagnoses were made between 1992 and 2009, and all patients were older than 65 years.
Risk of death from all causes decreased by age among the women who had breast cancer (30% for women ages 65 to 69 years; 26% for ages 70 to 74 years; 24% for ages 75 to 79). The risk of mortality was not significantly reduced for women older than 80 years.
However, this trend was not seen among men and women with colon cancer. Chemotherapy remained effective for these patients until age 89 years.
The investigators noted that previous research showed that chemotherapy is inefficient in patients older than 70 years with breast cancer, but the sample sizes were small. The larger sample size used in this study provides strong evidence to support this finding.
Chemotherapy does not improve survival for older women with breast cancer.
- Sexual Dysfunction in Women With Cancer: A Review of Available Interventions
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
- Lenalidomide After ASCT Prolongs Time to Progression in Multiple Myeloma
- Arthritis Medication Shows Potential in the Treatment of Polycythemia Vera
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|